Baudax Bio, Inc. (BXRXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 25, 2024, 8:30 AM EST
Baudax Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 |
| Net Income | -7.15 | -58.8 | -19.77 | -76.1 | -32.56 | -73.67 | Upgrade
|
| Depreciation & Amortization | 0.26 | 0.17 | 0.24 | 0.41 | 0.48 | 0.4 | Upgrade
|
| Other Amortization | 2 | 2 | 2.58 | 2.15 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.1 | 0.01 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 23.95 | 23.84 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.98 | 1.4 | 4.79 | 9.34 | 5.46 | 4.57 | Upgrade
|
| Other Operating Activities | -46.97 | 3.53 | -34.03 | 19.51 | -14.55 | 8.5 | Upgrade
|
| Change in Accounts Receivable | 0.21 | 0.21 | -0.49 | -0.05 | - | - | Upgrade
|
| Change in Inventory | -0.28 | -0.28 | -2.02 | -2.98 | - | - | Upgrade
|
| Change in Accounts Payable | 2.5 | -1.3 | -1.49 | 4.47 | -8.99 | 0.49 | Upgrade
|
| Change in Other Net Operating Assets | 0.03 | 1.44 | 0.92 | -0.8 | 0.12 | -0.05 | Upgrade
|
| Operating Cash Flow | -14.31 | -27.79 | -49.27 | -44.06 | -50.04 | -59.75 | Upgrade
|
| Capital Expenditures | -0.04 | -0.02 | -0.2 | -0.64 | -1.32 | -3.37 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -0.17 | -0.08 | Upgrade
|
| Investment in Securities | - | - | 0.01 | - | - | - | Upgrade
|
| Investing Cash Flow | 0.12 | -0.02 | -0.19 | -0.64 | -1.48 | -3.45 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 10.04 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -2.24 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -5.18 | -2.24 | - | 10.04 | - | - | Upgrade
|
| Issuance of Common Stock | 14.58 | 20.83 | 42.98 | 51.29 | 79.27 | 63.2 | Upgrade
|
| Repurchase of Common Stock | - | -0 | -0.1 | -0.48 | - | - | Upgrade
|
| Other Financing Activities | -0.5 | -1.41 | -7.87 | -3.56 | -10 | - | Upgrade
|
| Financing Cash Flow | 8.9 | 17.18 | 35.01 | 57.3 | 69.27 | 63.2 | Upgrade
|
| Net Cash Flow | -5.28 | -10.63 | -14.45 | 12.6 | 17.74 | - | Upgrade
|
| Free Cash Flow | -14.35 | -27.81 | -49.47 | -44.7 | -51.36 | -63.12 | Upgrade
|
| Free Cash Flow Margin | -1130.58% | -2191.73% | -4580.83% | -9066.33% | - | - | Upgrade
|
| Free Cash Flow Per Share | -3.60 | -83.87 | -903.81 | -3356.64 | - | - | Upgrade
|
| Levered Free Cash Flow | -15.93 | -10.06 | -30.58 | -18.4 | -35.73 | -61.15 | Upgrade
|
| Unlevered Free Cash Flow | -15.93 | -10.06 | -30.58 | -17.55 | -35.73 | -61.15 | Upgrade
|
| Change in Net Working Capital | -2.77 | -8.73 | 5.25 | -6.07 | 15.27 | 22.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.